N-acetyglucosamine derivatives and use thereof
Abstract
The present invention relates to An N-acetylglucosamine derivative represented by the following formula (1), and a hyaluronic acid production promoting agent containing the same and a skin external preparation containing the same: wherein R 1 is a hydrogen atom or an alkyl group having 2 to 18 carbon atoms; R 2 , R 3 , and R 4 are hydrogen atoms or acyl groups having 2 to 18 carbon atoms and may be all the same or different from others; the steric structure at position 1 may be α or β; provided that R 1 , R 2 , R 3 , and R 4 must not be all hydrogen atoms. It is intended to provide an easily available hyaluronic acid production promoting agent and a skin external preparation whereby the production of hyaluronic acid can be promoted in the skin and thus the skin can be maintained in a vital and moist state so that it is expected that the human skin can be prevented from age.
Claims
exact text as granted — not AI-modified1 . A method for promoting hyaluronic acid production in skin, comprising applying to the skin a composition comprising an N-acetylglucosamine derivative of formula (1):
wherein R 1 is a hydrogen atom or an alkyl group having 2 to 18 carbon atoms; R 2 , R 3 , and R 4 are hydrogen atoms or acyl groups having 2 to 18 carbon atoms and may be all the same or different from others; the steric structure at position 1 may be α or β; provided that R 1 , R 2 , R 3 , and R 4 must not be all hydrogen atoms.
2 . The method of claim 1 , wherein the N-acetylglucosamine derivative of the formula (1) is an N-acetylglucosamine derivative of formula (2) or (3):
wherein R 5 is an alkyl group having 2 to 18 carbon atoms; R 6 is a hydrogen atom or an acetyl group; and the steric structure at position 1 may be α or β; or
wherein R 7 is a hydrogen atom or an alkyl group having 2 to 18 carbon atoms; R 8 is an acyl group having 2 to 18 carbon atoms; and the steric structure at position 1 may be α or β.
3 . The method of claim 1 , wherein the N-acetylglucosamine derivative of the formula (1) is an N-acetylglucosamine derivative of formula (4):
wherein the steric structure at position 1 may be α or β.
4 . The method of claim 1 , wherein the N-acetylglucosamine derivative of the formula (1) is an N-acetylglucosamine derivative of formula (5):
wherein the steric structure at position 1 may be α or β.
5 . The method of claim 1 , wherein the N-acetylglucosamine derivative of the formula (1) is an N-acetylglucosamine derivative of formula (6):
wherein the steric structure at position 1 may be α or β.
6 . The method of claim 1 , wherein the N-acetylglucosamine derivative of the formula (1) is an N-acetylglucosamine derivative of formula (7):
wherein the steric structure at position 1 may be α or β.
7 . The method of claim 1 , wherein the N-acetylglucosamine derivative of the formula (1) is an N-acetylglucosamine derivative of formula (8):
wherein the steric structure at position 1 may be α or β.
8 . The method of claim 1 , wherein the N-acetylglucosamine derivative of the formula (1) is an N-acetylglucosamine derivative of formula (9):
wherein the steric structure at position 1 may be α or β.
9 . The method of claim 1 , wherein the N-acetylglucosamine derivative of the formula (1) is an N-acetylglucosamine derivative of formula (10):
wherein the steric structure at position 1 may be α or β.
10 . A method for promoting hyaluronic acid production in skin, comprising applying to the skin a composition comprising an N-acetylglucosamine derivative of formula (11):
wherein the steric structure at position 1 may be α or β.
11 . The method of claim 1 , wherein the N-acetylglucosamine derivative of the formula (1) is an N-acetylglucosamine derivative of formula (12):
wherein the steric structure at position 1 may be α or β.
12 . The method of claim 1 , wherein the N-acetylglucosamine derivative of the formula (1) is an N-acetylglucosamine derivative of formula (13):
wherein the steric structure at position 1 may be α or β.
13 . The method of claim 1 , wherein the N-acetylglucosamine derivative of the formula (1) is an N-acetylglucosamine derivative of formula (14):
wherein the steric structure at position 1 may be α or β.
14 . A method for promoting hyaluronic acid production in skin, comprising applying to the skin a composition comprising is an N-acetylglucosamine derivative of formula (15):
wherein the steric structure at position 1 may be α or β.
15 . A method for promoting hyaluronic acid production in skin, comprising applying to the skin a composition comprising an N-acetylglucosamine derivative of formula (16):
wherein R 9 is an acyl group having 2 to 16 carbon atoms and the steric structure at position 1 may be α or β.
16 . The method of claim 15 , wherein the N-acetylglucosamine derivative of the formula (16) is an N-acetylglucosamine derivative of formula (17):
wherein the steric structure at position 1 may be α or β.
17 . The method of claim 1 , wherein the method is for retaining vital, elastic, and moist skin.
18 . The method of claim 10 , wherein the method is for retaining vital, elastic, and moist skin.
19 . The method of claim 14 , wherein the method is for retaining vital, elastic, and moist skin.
20 . The method of claim 15 , wherein the method is for retaining vital, elastic, and moist skin.Join the waitlist — get patent alerts
Track US2008293673A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.